The Venture Codex Logo

The Venture Codex

Overview

Drug delivery and specialty pharmaceuticals with innovative syringe systems

Total Raised

$68 M

Rounds

3

Links

Verticals

Biopharma
Biotechnology
Health Care
Manufacturing
Pharmaceutical

Investment History

  1. Equity

    Sep 2021

    $40M

  2. Series B

    Aug 2018

    $13M

  3. Series A

    Sep 2016

    $15M

Team

Jeff Shanley

President and CEO

Dan Thayer

Co-Founder

Jeff Tillack

COO

John Merhige

Chief Commercial Officer